Cargando…

COVID-19 Infection Does Not Alter HLA Antibody Reactivity

Detalles Bibliográficos
Autores principales:	Johnson, Aileen C., Larsen, Christian P., Gebel, Howard, Bray, Robert
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299979/ https://www.ncbi.nlm.nih.gov/pubmed/35880144 http://dx.doi.org/10.1016/j.ekir.2022.07.011

Ejemplares similares

COVID-19 infection and vaccination rarely impact HLA antibody profile in waitlisted renal transplant candidates- a multicenter cohort
por: Roll, Garrett R., et al.
Publicado: (2023)

HLA Antibody Rates Are Not Increased in a Regional Group of Male COVID-19 Convalescent Plasma Donors
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Crystal structure of HLA-B*5801, a protective HLA allele for HIV-1 infection
por: Li, Xiaolong, et al.
Publicado: (2016)

COVID-19 vaccine does not alter panel reactive antibody or flow cytometric cross match in kidney transplant candidates
por: Kumar, Dhiren, et al.
Publicado: (2021)

COVID-19 does not impact HLA antibody profile in a series of waitlisted renal transplant candidates
por: Roll, Garrett R., et al.
Publicado: (2021)

Application of Calculated Panel Reactive Antibody Using HLA Frequencies in Koreans
por: Jang, Ji-Young, et al.
Publicado: (2012)

Two Cases of Antibody-Mediated Rejection Following Kidney Transplantation due to HLA-DQB1 Allele-Specific and DQ Alpha Protein-Specific HLA Antibodies
por: Song, Seung Hwan, et al.
Publicado: (2017)

False Positive Class II HLA Antibody Reaction Due to Antibodies Against Denatured HLA Might Differ Between Assays: One Lambda vs. Immucor
por: Park, Borae G., et al.
Publicado: (2020)

Full-length HLA sequencing in adult T cell leukemia–lymphoma uncovers multiple gene alterations
por: Tamaki, Keita, et al.
Publicado: (2021)

Pericyte alteration sheds light on micro-vasculopathy in COVID-19 infection
por: Cardot-Leccia, Nathalie, et al.
Publicado: (2020)

HLA antigens and anti-sperm antibody production in Iranian vasectomized men
por: Azizi, Gholamreza, et al.
Publicado: (2015)

Elevated Rate of HLA Antibodies in Male COVID-19 Convalescent Plasma Donors: A Risk Factor for Transfusion-Related Acute Lung Injury
por: Juskewitch, Justin E., et al.
Publicado: (2021)

Does cystic fibrosis constitute an advantage in COVID-19 infection?
por: Bezzerri, Valentino, et al.
Publicado: (2020)

Does type of immunosupression influence the course of Covid-19 infection?
por: Razanamahery, J., et al.
Publicado: (2020)

Evaluation of the Reactivity and Receptor Competition of HLA-G Isoforms toward Available Antibodies: Implications of Structural Characteristics of HLA-G Isoforms
por: Furukawa, Atsushi, et al.
Publicado: (2019)

ABO‐adjusted calculated panel reactive antibody (cPRA): A unified metric for immunologic compatibility in kidney transplantation
por: Gragert, Loren, et al.
Publicado: (2022)

Does exhaled aerosol increase with COVID-19 infection correlate with body mass index-years?
por: Stohner, Jürgen
Publicado: (2021)

Post-COVID-19 reactive arthritis
por: Slouma, Maroua, et al.
Publicado: (2022)

Establishment of Reference Values for Non-HLA Antibodies in Patients With End-stage Renal Disease
por: Shin, Kyung-Hwa, et al.
Publicado: (2023)

Bortezomib-Containing Multimodality Treatment for Antibody-Mediated Rejection with Anti-HLA and Anti-AT1R Antibodies after Kidney Transplantation
por: Iesari, Samuele, et al.
Publicado: (2017)

Neutralizing Antibodies against SARS-CoV-2 and HLA Class I and II Polymorphism
por: Weidner, Lisa, et al.
Publicado: (2021)

The influence of HLA genotype on the severity of COVID‐19 infection
por: Langton, David J., et al.
Publicado: (2021)

Generation and reactivity analysis of human recombinant monoclonal antibodies directed against epitopes on HLA‐DR
por: Kramer, Cynthia S. M., et al.
Publicado: (2020)

COVID-19 vaccine-associated reactivation of uveitis
por: Jain, Aarti, et al.
Publicado: (2021)

Myelin oligodendrocyte glycoprotein antibody‐associated optic neuritis in a post‐COVID‐19 infection patient
por: Zaini, Mohamad Azlan, et al.
Publicado: (2023)

Coeliac disease in the COVID-19 pandemic: does HLA have a protective effect?
por: Greco, N., et al.
Publicado: (2022)

Influence of HLA gene polymorphisms on susceptibility and outcome post infection with the SARS-CoV virus
por: Yuan, Fang Fang, et al.
Publicado: (2014)

Hemostatic alterations in COVID-19
por: Peyvandi, Flora, et al.
Publicado: (2020)

Impact of Donor-Specific anti-HLA Antibodies and Donor KIR Characteristics in Haploidentical HSCT for Beta-Thalassemia
por: Andreani, Marco, et al.
Publicado: (2017)

HLA and PF4 antibody production after adenoviral vector SARS-CoV-2 vaccination
por: Bouayad, Abdellatif
Publicado: (2021)

Does allergen immunotherapy impact the susceptibility and severity of COVID‐19?
por: Wang, Yin, et al.
Publicado: (2023)

Racial Disparities Between C-Reactive Protein and COVID-19 In-Hospital Outcomes
por: Sun, Wenjin
Publicado: (2022)

Preserved C-reactive protein responses to blood stream infections following tocilizumab treatment for COVID-19
por: Wey, Emmanuel Q., et al.
Publicado: (2021)

Fibrillary Glomerulonephritis Is Associated With HLA-DR7 and HLA-B35 Antigens
por: Andeen, Nicole K., et al.
Publicado: (2020)

Being Reactive: Assessing Affect in the COVID-19 Era
por: Goldenberg, Matthew N., et al.
Publicado: (2020)

Comment on: COVID-19 vaccine-associated reactivation of uveitis
por: Sanjay, Srinivasan, et al.
Publicado: (2022)

Cytomegalovirus Reactivation in Critically-ill COVID-19 Patients
por: Talan, Leyla, et al.
Publicado: (2022)

Revisiting reactive arthritis during the COVID-19 pandemic
por: Bekaryssova, Dana, et al.
Publicado: (2022)

Does Carbamazepine Alter the Electro-Convulsive Threshold?
por: Sharma, P.S.V.N., et al.
Publicado: (1985)

No serological evidence for neuronal damage or reactive gliosis in neuro-COVID-19 patients with long-term persistent headache
por: de Boni, Laura, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lo8ei4l6dl1dhv891d8j41d7do